Published in Br J Cancer on July 27, 2010
Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int J Cancer (2011) 1.79
Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov (2012) 1.71
Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype. Environ Health Perspect (2012) 1.66
Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone Marrow Res (2012) 1.51
Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Mol Cancer (2017) 1.39
Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 mice. Toxicol Sci (2010) 1.33
Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations. EMBO Mol Med (2012) 1.22
Arsenic, stem cells, and the developmental basis of adult cancer. Toxicol Sci (2010) 1.09
Gastric cancer stem cells: a novel therapeutic target. Cancer Lett (2013) 1.04
The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression. PLoS One (2011) 1.01
Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines. Cancers (Basel) (2011) 0.99
Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis. BMC Cancer (2014) 0.93
Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity. Oncogene (2012) 0.91
Liposarcoma Cells with Aldefluor and CD133 Activity have a Cancer Stem Cell Potential. Clin Sarcoma Res (2011) 0.89
Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis. J Biol Chem (2014) 0.88
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma. PLoS One (2011) 0.88
Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells. Proc Natl Acad Sci U S A (2015) 0.86
Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype. Chem Res Toxicol (2012) 0.85
Induced pluripotent cancer cells: progress and application. J Cancer Res Clin Oncol (2010) 0.85
Population genetics of cancer cell clones: possible implications of cancer stem cells. Theor Biol Med Model (2010) 0.84
The inhibitory effect of rapamycin on the oval cell response and development of preneoplastic foci in the rat. Exp Mol Pathol (2012) 0.84
Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia. Stem Cells Int (2015) 0.82
Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma. Int J Clin Exp Pathol (2011) 0.82
Embryonic signature in breast cancers; Pluripotency roots of cancer stem cells. Saudi Pharm J (2012) 0.81
The androgen receptor and stem cell pathways in prostate and bladder cancers (review). Int J Oncol (2011) 0.81
CD44v6 expression in human skin keratinocytes as a possible mechanism for carcinogenesis associated with chronic arsenic exposure. Eur J Histochem (2013) 0.80
Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis. Sci Rep (2015) 0.79
Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer. Histopathology (2012) 0.79
Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors. Cancer Biol Ther (2015) 0.78
Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma. J Pathol Transl Med (2015) 0.78
Treatment of agarose-agarose RENCA macrobeads with docetaxel selects for OCT4(+) cells with tumor-initiating capability. Cancer Biol Ther (2013) 0.77
Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysis. Onco Targets Ther (2016) 0.77
Targeting metabolism and autophagy in the context of haematologic malignancies. Int J Cell Biol (2012) 0.77
Stem cells: a model for screening, discovery and development of drugs. Stem Cells Cloning (2011) 0.76
Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration. Toxicol Appl Pharmacol (2015) 0.76
Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma. Oncol Lett (2012) 0.76
Recruitment of normal stem cells to an oncogenic phenotype by noncontiguous carcinogen-transformed epithelia depends on the transforming carcinogen. Environ Health Perspect (2013) 0.76
The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers. J Ovarian Res (2012) 0.75
C-KIT-positive undifferentiated tumor of the liver: A case report. Oncol Lett (2014) 0.75
The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres. Genomics (2011) 0.75
A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancer. Chin J Cancer (2012) 0.75
A possible explanation for the variable frequencies of cancer stem cells in tumors. PLoS One (2013) 0.75
MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1. Sci Rep (2017) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 21.59
Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature (2003) 14.35
Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res (2005) 13.89
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature (2003) 12.06
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature (2006) 11.86
Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A (2003) 10.56
Tumor growth need not be driven by rare cancer stem cells. Science (2007) 10.34
Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ (2007) 8.08
A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res (2005) 7.86
Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell (2009) 7.09
Stem cell concepts renew cancer research. Blood (2008) 6.74
Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell (2005) 6.29
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell (2004) 5.98
Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology (2007) 5.75
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res (2007) 5.32
Cancer stem cells: mirage or reality? Nat Med (2009) 5.20
Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol (2004) 5.10
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev (2003) 4.71
Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell (2009) 4.43
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science (2010) 4.37
Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell (2007) 4.21
Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells (2009) 4.08
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res (2005) 3.79
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle (2009) 3.60
Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science (2008) 3.38
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res (2009) 3.30
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood (2005) 3.22
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood (2008) 3.19
The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood (2009) 2.85
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell (2008) 2.78
Characterization of acute lymphoblastic leukemia progenitor cells. Blood (2004) 2.65
A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood (2000) 2.42
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med (2005) 2.36
Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. Cancer Cell (2008) 2.35
Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci U S A (2009) 2.11
CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev (2009) 2.10
A QUANTITATIVE ASSAY FOR THE NUMBER OF MURINE LYMPHOMA CELLS CAPABLE OF PROLIFERATION IN VIVO. Nature (1963) 1.96
Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell (2010) 1.92
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. Blood (2009) 1.89
Cancer stem cells: back to Darwin? Semin Cancer Biol (2010) 1.65
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. Cancer Res (2005) 1.55
Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol (2009) 1.42
CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia (2008) 1.39
Punish the parent not the progeny. Blood (2004) 1.32
Studies of the quantitative transplantation of mouse sarcoma. Br J Cancer (1953) 1.30
Further evidence favoring the concept of the stem cell in ascites tumors of rats. Ann N Y Acad Sci (1956) 1.14
Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro Oncol (2008) 1.12
The cancer stem cell microenvironment and anti-cancer therapy. Int J Radiat Biol (2009) 0.91
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. Clin Cancer Res (2009) 0.89
Studies on the number of cells necessary for the transplantation of Yoshida sarcoma; transmission of the tumor with a single cell. Gan (1950) 0.81
An experimental brainstem tumor model using in vivo bioluminescence imaging in rat. Childs Nerv Syst (2009) 0.79
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 21.59
Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med (1996) 4.42
New insights to the MLL recombinome of acute leukemias. Leukemia (2009) 4.07
The MLL recombinome of acute leukemias in 2013. Leukemia (2013) 2.55
Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia (1996) 1.96
Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J Biol Chem (1994) 1.76
Rapid PCR method for site-directed mutagenesis on double-stranded plasmid DNA. Biotechniques (1996) 1.46
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia (2012) 1.35
Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J Clin Invest (1995) 1.25
Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Hum Mol Genet (1995) 1.14
Good engraftment of B-cell precursor ALL in NOD-SCID mice. Klin Padiatr (1997) 1.12
Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene (1996) 1.12
A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin. Leukemia (2008) 1.08
siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts. Oncogene (2006) 1.05
Adenosine response of the rat kidney after saline loading, sodium restriction and hemorrhagia. Pflugers Arch (1975) 1.03
Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT. Leukemia (2010) 0.99
Triphasic effect of prostaglandins E1, E2 and F2alpha on the fluid transport of isolated gall-bladder of guinea-pigs. Prostaglandins (1975) 0.98
Osteosarcoma after allogeneic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS). Bone Marrow Transplant (2003) 0.94
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant (2004) 0.94
The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO. Oncogene (2011) 0.94
Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia. Eur J Pediatr (2001) 0.93
Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr (1999) 0.92
Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report. Leukemia (2011) 0.92
Binding and functional effects of transcriptional factor Sp1 on the murine interleukin-6 promotor. J Biol Chem (1996) 0.92
Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant (2005) 0.90
Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice. Blood (1996) 0.89
CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells. Clin Exp Immunol (2006) 0.88
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol (2004) 0.86
Evaluation of the effectiveness of DNA-binding drugs to inhibit transcription using the c-fos serum response element as a target. Biochemistry (2000) 0.86
Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression. Leukemia (2012) 0.86
Sequence requirements of ATF2 and CREB binding to the human T-cell leukemia virus type 1 LTR R region. Virology (1996) 0.86
PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death. Br J Cancer (2005) 0.86
Targeting CD19 with genetically modified EBV-specific human T lymphocytes. Ann Hematol (2002) 0.85
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia. Bone Marrow Transplant (2007) 0.85
Transient depletion of RUNX1/RUNX1T1 by RNA interference delays tumour formation in vivo. Leukemia (2008) 0.85
Adoptive cellular immunotherapy with CD19-specific T cells. Klin Padiatr (2005) 0.84
Expression of AC133 and CD117 on candidate normal stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia. Br J Haematol (1999) 0.84
Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide. Klin Padiatr (2006) 0.81
Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia. Leukemia (2000) 0.80
Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11). Br J Haematol (2006) 0.80
Farber's disease without central nervous system involvement: bone-marrow transplantation provides a promising new approach. Ann Rheum Dis (2006) 0.80
Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo. Leukemia (2010) 0.80
Design of hammerhead ribozymes for the inhibition of gene expression ex vivo by exogenous application. Nucleic Acids Symp Ser (1993) 0.80
Inhibition of fluid transport in the isolated gall bladder of the guinea pig by isoprenaline, theophylline and cyclic adenosine 3',5'-monophosphate. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.79
Increased DNA-repair capacity and the modulation of 2 proteins in and metallothionein overexpressing Chinese hamster cell line. Mutat Res (1994) 0.78
AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia. Leukemia (2011) 0.78
Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes. Eur J Biochem (2001) 0.78
A micropuncture study of the effect of isoprenaline on renal tubular fluid and electrolyte transport in the rat. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.78
Effect of radiation on Ewing tumour subpopulations characterized on a single-cell level: intracellular cytokine, immunophenotypic, DNA and apoptotic profile. Int J Radiat Biol (2003) 0.77
Cell heterogeneity and subpopulations in solid tumors characterized by simultaneous immunophenotyping and DNA content analysis. Cytometry (2000) 0.77
Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients. Br J Haematol (1999) 0.77
Structure-function relationship of hammerhead ribozymes as probed by 2'-modifications. Nucleic Acids Symp Ser (1991) 0.77
Role of kinases in HTLV-I transformation. J Investig Med (1996) 0.77
Bordetella pertussis respiratory infection following hematopoietic stem cell transplantation: time for universal vaccination? Bone Marrow Transplant (2006) 0.76
Diuretic agents: actions on a molecular level. Clin Exp Hypertens A (1983) 0.76
[Transient myeloproliferation and acute myeloid leukemia in infants with Down's syndrome]. Klin Padiatr (1990) 0.76
Metastatic neuroblastoma demonstrated by whole-body PET-CT using 11C-HED. Nuklearmedizin (2005) 0.75
A new affinity purification procedure for DNA-binding proteins using bromoacetyl agarose. Nucleic Acids Res (1995) 0.75
[Substitution experiments with various potassium salts in potassium deficient rats]. Klin Wochenschr (1972) 0.75
Studies with the optically active isomers of the new diuretic drug ozolinone. I. Differences in stereoselectivity of the renal target structures of ozolinone. Pflugers Arch (1980) 0.75
[The effect of eledoisin on kidney function in dogs]. Arch Int Pharmacodyn Ther (1965) 0.75
[Problems with the addition of sulfite to infusion solutions]. Infusionsther Klin Ernahr (1984) 0.75
Studies with the optically active isomers of the new diuretic drug ozolinone. II. Inhibition by d-ozolinone of furosemide-induced diuresis. Pflugers Arch (1980) 0.75
[Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood]. Klin Padiatr (1996) 0.75
[Pharmacologic problems of the coronary circulation]. Hippokrates (1966) 0.75
Effects of ozolinone, a diuretic active metabolite of etozoline, on renal function. I. Clearance studies in dogs. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.75
Heterogeneity of radiation induced apoptosis in Ewing Tumor cell lines characterized on a single cell level. Apoptosis (2005) 0.75
[Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study]. Klin Padiatr (2002) 0.75
[The effect of calcium and potassium ions on the diuretic action of cardiac glycosides in dogs]. Naunyn Schmiedebergs Arch Pharmakol Exp Pathol (1966) 0.75
[Comparative studies on the diuretic effect and acute toxicity of g-strophanthin, scillaren and proscillaridin in dogs]. Arch Int Pharmacodyn Ther (1967) 0.75
Renal actions of azosemide. 2. Micropuncture investigations in rats. Arzneimittelforschung (1981) 0.75
Pharmacological basis of the action of diuretics. Contrib Nephrol (1980) 0.75
[Behavior of water electrolyte balance in the rat under the influence of 3,4',7-trihydroxyflavanone-3-di-D-hexuronic acid methylester]. Arzneimittelforschung (1974) 0.75
[Mode of action of the antihypertensive agents]. Med Klin (1970) 0.75
[Recommendations for the evaluation of infusion solutions]. Infusionsther Klin Ernahr (1978) 0.75
Time- and dose-dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation. Int J Radiat Biol (2003) 0.75
[Extracardiac effects of digitalis glycosides]. Verh Dtsch Ges Herz Kreislaufforsch (1982) 0.75
Stereospecific inhibition by ozolinone of stimulated chloride secretion in rabbit colon descendens. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.75
Effect of Etozolin on whole kidney function and fluid and electrolyte reabsorption in rat proximal convoluted tubules and loops of Henle. Arzneimittelforschung (1977) 0.75
Molecular actions of diuretics. Klin Wochenschr (1982) 0.75
[Hydromorphon injection in pronouced obesity]. Dtsch Med Wochenschr (1977) 0.75
Adenovirus-mediated interferon-gamma transfer inhibits growth of transplanted HTLV-1 Tax tumors in mice. Hum Gene Ther (1996) 0.75
Effects of ozolinone, a diuretic active metabolite of etozoline, on renal function. II. Localization of tubular site of diuretic action by micropuncture in the rat. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.75
[On the renal excretion of Tris buffer (THAM) and the anion pattern of the urine]. Med Pharmacol Exp Int J Exp Med (1967) 0.75
Tissue levels of cyclic nucleotides in the rat kidney after administration of furosemide. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.75
[Pharmacology of diuretics]. Z Allgemeinmed (1974) 0.75
[Effect upon the kidney of calcium salts during different states of diuresis in the dog]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.75
Effects of ethacrynic acid on electrolyte and fluid transport by the guinea pig gallbladder. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.75
[The effect of potassium chloride and organic potassium salts on the acid-base equilibrium in normo and hypokalemic rats]. Infusionsther Klin Ernahr (1975) 0.75
Renal actions of azosemide. 1. Clearance investigations in dogs. Arzneimittelforschung (1981) 0.75
Mode of action of conventional and potassium-sparing diuretics--aspects with relevance to Mg-sparing effects. Review of the present state of the art and recent findings. Magnesium (1984) 0.75
[The mechanism of action of diuretics]. Med Monatsschr (1966) 0.75
Attenuation by d-ozolinone of l-ozolinone-induced diuresis in rats. Eur J Pharmacol (1984) 0.75
Renal effects of torasemide in the rat. Clearance and micropuncture studies. Arzneimittelforschung (1985) 0.75
[The effect of the plasma substitutes hydroxyethyl starch and dextrane-60 on the kidney function of dogs in acute haemorrhagic shock (author's transl)]. Anaesthesist (1975) 0.75